Drug Discovery and Development Industry Market Research Reports in India, May 2013

Investor presentation: Drug Discovery and Development in Brazil, India and China for Year 2012

• Company report
• March 2012
• 19 pages
• by Corporation

... Potent, pan-genotypic activity in vitro - clean safety - low potential for drug-drug interactions Three-day proof-of-concept clinical trial in 64 hcv-infected patients demonstrated safety and pan ...

• Industries: Drug Discovery and Development
• Countries: Brazil, India, China

Investor presentation: Drug Discovery and Development in Brazil and India for Year 2012

• Company report
• March 2012
• 19 pages
• by Corporation

... Pan-genotypic activity in vitro - clean safety - low potential for drug-drug interactions Three-day proof-of-concept clinical trial in 64 hcv-infected patients demonstrated safety and pan ...

• Industries: Drug Discovery and Development
• Countries: World, Brazil, India

Investor presentation: Drug Discovery and Development in Brazil, India and China for Year 2012

• Company report
• March 2012
• 19 pages
• by Corporation

... In vitro (2-24 pm) - clean safety - low potential for drug-drug interactions Three-day proof-of-concept clinical trial in 64 hcv-infected patients demonstrated safety and pan-genotypic activity ...

• Industries: Drug Discovery and Development
• Countries: Brazil, India, China

Company Report: Drug Discovery and Development in The United States and India for Year 2012

• Company report
• March 2012
• 7 pages
• by Corporation

• Industries: Drug Discovery and Development
• Countries: United States, India

Investor presentation: Drug Discovery and Development in India, The United States and Japan for Year 2012

• Company report
• March 2012
• 31 pages
• by Corporation

• Industries: Drug Discovery and Development
• Countries: India, United States, Japan

Company Report: Clinical Trial in Russian Federation and India for Year 2012

• Company report
• February 2012
• 19 pages

... Diabetes as well as an inhaled version for the treatment of a central nervous system (cns) indication. Sulixen has completed phase i human clinical trials in russia for the diabetes indications ...

• Industries: Drug Discovery and Development
• Countries: Russian Federation, India

Investor presentation: Drug Discovery and Development in India, The United States and Japan for Year 2012

• Company report
• March 2012
• 35 pages
• by Corporation

... Engaged in manufacture and supply of apis, generics, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery and development ...

• Industries: Drug Discovery and Development
• Countries: India, United States, Japan

Company Report: Drug Discovery in India for Year 2012

• Company report
• May 2012
• 9 pages

... Unmet needs such as cancer, neurodegeneration, inflammation, diabetes/metabolic disorders, infections and cardiovascular disorders. This opportunity is at the leading edge of drug discovery research ...

• Industries: Drug Discovery and Development
• Countries: India

Company Report: Drug Discovery and Development in The United States, Greece and India for Year 2011

• Company report
• December 2011
• 3 pages

... Provider capable of analyzing and predicting industry trends. The purchase, which will cost piramal healthcare $635 million, will help the company S nascent drug discovery business predict emerging trends ...

• Industries: Drug Discovery and Development
• Countries: United States, Greece, India

Company Report: Drug Discovery and Development in India for Year 2012

• Company report
• October 2012
• 26 pages
• by Corporation

... Analytics in clinical studies to drive performance 3 key success factors for establishing strategic partnerships in cdm, bsp and medical writing India as a key destination 8 interview alexander ...

• Industries: Drug Discovery and Development
• Countries: India

Company Report: Drug Discovery and Development in The United States, India and Brazil for Year 2013

• Company report
• February 2013
• 19 pages

• Industries: Drug Discovery and Development
• Countries: United States, India, Brazil

Company Report: Drug Discovery and Development in India for Year 2012

• Company report
• September 2012
• 28 pages
• by Bank

... Mn) company overview diagnosearch life sciences (dls) is a full service clinical trials outsourcing company providing its customers with clinical trials and clinical research services ...

• Industries: Drug Discovery and Development
• Countries: India

Company Report: Clinical Trial in India for Year 2011

• Company report
• December 2011
• 3 pages
• by Corporation

... Rating sensitivities. Company profile incorporated in 1999, ltrl is a full service clinical research organization. It is promoted by chudgar family and belongs to intas group of ahmedabad, which ...

• Industries: Drug Discovery and Development
• Countries: India

Transgene Biotek Ltd. - Company Report for Year 2012

• Company report
• August 2012
• 4 pages

... Oral insulin project and monoclonal antibodies programs) - which should be translated to shareholder optimism. After years of pioneering drug discovery activity the company is finally seeing the light ...

• Industries: Drug Discovery and Development
• Countries: India

Company Report: Clinical Trial in India and The United States for Year 2011

• Company report
• December 2011
• 3 pages
• by Corporation

... Technology and medical devices sectors in compliance with international standards. Siro carries out comprehensive, independent management of phase i to phase iv clinical trials. However, the company S primary focus ...

• Industries: Drug Discovery and Development
• Countries: India, United States

Clinical Research in India : Innovation and Technology Trends

• Industry report
• January 2012
• 28 pages

... Is emerging as one of the fastest recruiter of subjects across the world. Some of the top medical/technical universities in asia an iso 9001:2000 certified academycliniminds academy for clinical research ...

• Industries: Drug Discovery and Development
• Countries: India

Clinical Trial in India : Innovation and Technology Trends

• Industry report
• January 2012
• 6 pages

... Of it. India is in the transforming phase of preparation of guidelines and rules for clinical research. This will take some time to streamline the clinical research process. New destinations such as latin ...

• Industries: Drug Discovery and Development
• Countries: India

Clinical Trial in The United States and India : Innovation and Technology Trends

• Industry report
• January 2012
• 18 pages

... Confirmatory clinical trial ready to be marketed as medical food/ medical product erectile dysfunction e-mh-07 market size More than $2.07 Billion expended for evaluation and treatment of kidney stones ...

• Industries: Drug Discovery and Development
• Countries: United States, India

Clinical Trial in India : Innovation and Technology Trends

• Industry report
• February 2012
• 20 pages

... Of 60% as compared to the us Outcomes based pricing key features of eccro S full cro service offering 3 location of eccro office and partner clinical trial sites mumbai eccro india office bangalore ...

• Industries: Drug Discovery and Development
• Countries: India

The Indian Clinical Trial Market : Innovation and Technology Trends

• Industry report
• December 2011
• 5 pages

... New destinations such as latin america, africa, indonesia, malaysia and philippines have been emerging as a hub of clinical research. Industry is still moving with hope and will be able to progress ...

• Industries: Drug Discovery and Development
• Countries: India

The Indian Drug Discovery and Development Business : Innovation and Technology Trends

• Industry report
• December 2011
• 7 pages

... To not only indian companies in terms of restoration of their market share but is also good in public interest as monopoly of medicines is curtailed. clinical research outsourcing in past few years ...

• Industries: Drug Discovery and Development
• Countries: India

The Indian Clinical Trial Market : Innovation and Technology Trends

• Industry report
• March 2012
• 28 pages

... Background data entry of case report forms (crfs), as part of clinical trials phase ii and iii, was expensive, time consuming, and created a bottleneck in proceeding to the next stages of review ...

• Industries: Drug Discovery and Development
• Countries: India

Clinical Trial in India : Innovation and Technology Trends

• Industry report
• August 2012
• 24 pages

... For monitoring visits eccro partner clinical trial sites are managed and supported so as to meet our productivity & quality metrics 18 location of eccro office and partner clinical trial sites mumbai eccro ...

• Industries: Drug Discovery and Development
• Countries: India

The Indian Clinical Trial Market : Innovation and Technology Trends

• Industry report
• January 2013
• 27 pages

... Such as clinical trial conduct and drug safety * biotech products, biosimilars * pharmacogenomics, personalized medicine - increased sourcing * edc/rdc reduce the volume of data management tasks, but make ...

• Industries: Drug Discovery and Development
• Countries: India

Drug Discovery and Development in Australia and India : Innovation and Technology Trends

• Industry report
• January 2013
• 18 pages

... A common bond was a tacitly agreed permissiveness - carte blanche for whatever your vision to future progress might be. Crisis in drug discovery Opportunities: Aging population in west More ...

• Industries: Drug Discovery and Development
• Countries: Australia, India

Drug Discovery and Development in India : Innovation and Technology Trends

• Industry report
• April 2012
• 3 pages

... drug research. The indian bio Pharmaceutical industry is in its emerging stage and is sized at about $1.4 Billion as of 2010 11. However, indian bio Pharmaceutical players largely market vaccines ...

• Industries: Drug Discovery and Development
• Countries: India

Drug Discovery and Development Sector Analysis in India and The United States

• Industry report
• March 2012
• 163 pages

• Industries: Drug Discovery and Development
• Countries: India, United States

Drug Discovery and Development Business in India and Canada

• Industry report
• February 2012
• 21 pages

... A proven track record as modulators of protein:protein interactions but often are hard to place onto the drug discovery path Natural product- inspired small molecule tool box 9 Natural product ...

• Industries: Drug Discovery and Development
• Countries: India, Canada

The Indian Clinical Trial Market : Innovation and Technology Trends

• Industry report
• February 2013
• 5 pages

... The challenges of proving its efficiency as the preferred destination for global clinical trials. A number of factors favour india as a clinical research hub. Firstly, there are numerous government funded medical ...

• Industries: Drug Discovery and Development
• Countries: India

Drug Discovery and Development in India and Canada : Innovation and Technology Trends

• Industry report
• February 2012
• 21 pages

... Pharmaceutical industry for low cost, highly innovative drug discovery through building strategic partnerships. 9 To leverage arya research expertise in natural product-inspired diversity ...

• Industries: Drug Discovery and Development
• Countries: India, Canada